Download FREE Report Sample
Download Free sampleAutoimmune disease is a condition in which the immune system is unable to recognize the body?s own cells and starts attacking them. The immune system might attack different types of body cells, depending on which the autoimmune disease is classified. This disease might result in degradation as well as improper functioning of body organs.
Autoimmune Disease Drug Market contains market size and forecasts of Autoimmune Disease Drug in Global, including the following market information:
Global Autoimmune Disease Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Autoimmune Disease Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
NSAIDs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Autoimmune Disease Drug include Abbott Laboratories, Pfizer, AbbVie, Eli Lilly, Bristol-Myers Squibb, AstraZeneca plc, GlaxoSmithKline, Roche and Biogen and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Autoimmune Disease Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Autoimmune Disease Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Autoimmune Disease Drug Market Segment Percentages, by Type, 2021 (%)
NSAIDs
Anti-Inflammatory
Interferons
Antihyperglycemics
Others
Global Autoimmune Disease Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Autoimmune Disease Drug Market Segment Percentages, by Application, 2021 (%)
Rheumatoid Arthritis
Type 1 Diabetes
Multiple Sclerosis
Psoriasis
Lupus
Inflammatory Bowel Disease
Others
Global Autoimmune Disease Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Autoimmune Disease Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Autoimmune Disease Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Autoimmune Disease Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Pfizer
AbbVie
Eli Lilly
Bristol-Myers Squibb
AstraZeneca plc
GlaxoSmithKline
Roche
Biogen
Amgen
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
